JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5276
State Street SPDR S&P Transportation ETF
XTN
$307M
| $190K | ﹤0.01% |
2,195
-1,600
| -42% | -$141K |
2017 Q1
31 quarters
|
|
5277
Gilat Satellite Networks
GILT
$773M
| $190K | ﹤0.01% |
30,868
-24,041
| -44% | -$131K |
2019 Q3
21 quarters
|
|
5278
FT Vest US Equity Buffer ETF December
FDEC
$1.33B
| $190K | ﹤0.01% |
+4,254
| New | +$189K |
2024 Q4
0 quarters
|
|
5279
Mammoth Energy Services
TUSK
$135M
| $189K | ﹤0.01% |
63,079
+51,919
| +465% | +$191K |
2016 Q4
32 quarters
|
|
5280
Innovator US Equity Accelerated 9 Buffer ETF January
XBJA
$93.9M
| $189K | ﹤0.01% |
+6,561
| New | +$187K |
2024 Q4
0 quarters
|
|
5281
PUT
Nutrien
NTR
$33.4B
| $188K | ﹤0.01% |
4,200
| – | – |
2023 Q4
4 quarters
|
|
5282
CALL
Transocean
RIG
$5.77B
| $188K | ﹤0.01% |
50,000
| – | – |
2021 Q2
14 quarters
|
|
5283
FT Vest US Equity Moderate Buffer ETF February
GFEB
$383M
| $187K | ﹤0.01% |
5,016
-5,945
| -54% | -$220K |
2024 Q1
3 quarters
|
|
5284
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$360M
| $187K | ﹤0.01% |
2,982
+378
| +15% | +$23.5K |
2023 Q2
6 quarters
|
|
5285
ChargePoint
CHPT
$249M
| $187K | ﹤0.01% |
8,736
-133
| -1% | -$3.29K |
2020 Q1
19 quarters
|
|
5286
Karyopharm Therapeutics
KPTI
$18.2M
| $187K | ﹤0.01% |
18,414
-73,968
| -80% | -$894K |
2013 Q4
44 quarters
|
|
5287
Invesco Fundamental Investment Grade Corporate Bond ETF
PFIG
$122M
| $187K | ﹤0.01% |
+7,947
| New | +$189K |
2024 Q4
0 quarters
|
|
5288
CALL
GoodRx Holdings
GDRX
$1.12B
| $186K | ﹤0.01% |
+40,000
| New | +$220K |
2024 Q4
0 quarters
|
|
5289
Scilex Holding
SCLX
$28.6M
| $186K | ﹤0.01% |
12,447
| – | – |
2023 Q1
7 quarters
|
|
|
MITT
5290
TPG Mortgage Investment Trust
MITT
$183M
| $186K | ﹤0.01% |
27,919
-7,701
| -22% | -$54.5K |
2015 Q4
36 quarters
|
|
5291
iShares MSCI Emerging Markets Asia ETF
EEMA
$902M
| $186K | ﹤0.01% |
2,589
-371
| -13% | -$28.1K |
2019 Q2
22 quarters
|
|
5292
Franklin US Treasury Bond ETF
FLGV
$1.02B
| $185K | ﹤0.01% |
9,186
-3,051
| -25% | -$62.4K |
2023 Q3
5 quarters
|
|
5293
Quantum Computing Inc
QUBT
$1.85B
| $184K | ﹤0.01% |
11,101
+10,945
| +7,016% | +$60.1K |
2023 Q4
4 quarters
|
|
5294
FT Vest US Equity Buffer ETF February
FFEB
$1.43B
| $184K | ﹤0.01% |
3,687
-7,188
| -66% | -$355K |
2024 Q3
1 quarter
|
|
5295
Franklin FTSE Japan Hedged ETF
FLJH
$235M
| $183K | ﹤0.01% |
5,843
+2,715
| +87% | +$85K |
2024 Q2
2 quarters
|
|
|
FLNA
5296
PUT
Filana Therapeutics
FLNA
$45M
| $183K | ﹤0.01% |
+77,500
| New | +$1.36M |
2024 Q4
0 quarters
|
|
5297
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.1B
| $181K | ﹤0.01% |
7,280
+6,096
| +515% | +$153K |
2024 Q1
3 quarters
|
|
5298
STRATTEC Security
STRT
$262M
| $181K | ﹤0.01% |
4,392
+2,777
| +172% | +$111K |
2024 Q3
1 quarter
|
|
5299
GrowGeneration
GRWG
$92.5M
| $181K | ﹤0.01% |
106,932
-18,197
| -15% | -$34.8K |
2020 Q2
18 quarters
|
|
5300
Assembly Biosciences
ASMB
$459M
| $180K | ﹤0.01% |
11,427
+7,918
| +226% | +$127K |
2017 Q2
30 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.